Study Data from Capital Medical University Update Understanding of Personalized Medicine (A new prognostic scoring system for newly diagnosed multiple myeloma in the era of new drugs).

A study conducted by Capital Medical University in Beijing, China, has developed a new prognostic scoring system for newly diagnosed multiple myeloma patients. The system categorizes patients into low, intermediate, and high-risk groups based on specific clinical and cytogenetic factors, showing good discrimination and calibration. This personalized approach aims to improve risk assessment and guide treatment strategies for individuals with multiple myeloma. [Extracted from the article]